ABCLABCELLERA BIOLOGICS INC
CUSIP 00288U106 · common stock
4 tracked investors held ABCELLERA BIOLOGICS INC (ABCL) at the end of Q3 2026, worth $496.1M in total. The largest holder was Julian Baker, with 2.3% of its portfolio. 3 investors opened new positions this quarter, including Adar1 Capital Management.
Holders · Q3 2026
4
New holders
3
Value held
$496.1M
Quarter-end price (est.)
$14.59
Investors holding ABCL · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 2.29% | 33,012,139 | $481.6M | ADD0.0% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.51% | 822,163 | $12M | NEW |
| George Soros Soros Fund Management LLC | 0.03% | 150,000 | $2.2M | NEW |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 17,318 | $252.7K | NEW |